Journal article

Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's disease

Yue Huang, Glenda M Halliday, Himesha Vandebona, George D Mellick, Frank Mastaglia, Julia Stevens, John Kwok, Michael Garlepp, Peter A Silburn, Malcolm K Horne, Katya Kotschet, Alison Venn, Dominic B Rowe, Justin P Rubio, Carolyn M Sue



We determined the prevalence of two common leucine-rich repeat kinase 2 (LRRK2) gene mutations in Australian patients with Parkinson's disease (PD). Of 830 affected patients, eight were heterozygous for the G2019S mutation, and two were heterozygous for the R1441H (4,322 G > A) mutation. In addition, one familial patient had a novel A1442P (4,324 G > C) mutation. Haplotype analysis showed that all LRRK2 G2019S-positive individuals carried the common founder haplotype 1 and a putative founder haplotype for the R1441H mutation carriers. Clinically, patients with LRRK2 mutations had typical levodopa responsive Parkinsonism with tremor being the commonest presenting feature. Patients with the G2..

View full abstract